Financial statements Pharmfactor
Balance sheet of Pharmfactor
Company age:
Age:
8 y. 4 m. 14 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of PHARMFACTOR
|
Year
|
2017
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 2 170 648,23 | 3 399 605,24 | 3 937 014,55 | 3 309 959,32 | 3 136 656,28 |
| A. Fixed assets | 314 030,75 | 706 691,78 | 859 346,61 | 859 023,38 | 831 658,21 |
| B. Current assets | 1 856 617,48 | 2 692 913,46 | 3 077 667,94 | 2 450 935,94 | 2 304 998,07 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 170 648,23 | 3 399 605,24 | 3 937 014,55 | 3 309 959,32 | 3 136 656,28 |
| A. Equity | -1 465 833,05 | 1 415 494,30 | 744 661,16 | 54 046,30 | -1 439 258,86 |
| B. Liabilities and provisions for liabilities | 3 636 481,28 | 1 984 110,94 | 3 192 353,39 | 3 255 913,02 | 4 575 915,14 |
| I. Long-term liabilities | 0,00 | 461 663,60 | 1 380 163,60 | 1 520 163,60 | 2 975 163,60 |
| II. Short-term liabilities | 3 243 763,47 | 515 439,48 | 769 147,51 | 916 212,66 | 1 004 720,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.